Literature DB >> 27311520

Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.

Min Jung Ko1, Ae Jung Jo1, Chan Mi Park1, Hyo Jeong Kim1, Yun Jung Kim1, Duk-Woo Park2.   

Abstract

BACKGROUND: Blood pressure (BP) targets from the SPRINT (Systolic Blood Pressure Intervention Trial) differ from targets of the 2014 hypertension (HTN) recommendations of the Eighth Joint National Committee.
OBJECTIVES: The goal of this study was to estimate the proportion of hypertensive adults with who would meet BP goals under the SPRINT criteria and under the 2014 recommendations, and to determine related effects on cardiovascular morbidity and mortality.
METHODS: We used data from the Korean National Health and Nutrition Examination Survey of 2008 to 2013 (n = 13,346), as well as the Korean National Health Insurance Service health examinee cohort of 2007 (n = 67,965), to estimate the proportion of subjects meeting BP goals of each of the criteria. Using data from the Korean National Health Insurance Service health examinee cohort of 2007 (n = 67,965), we compared risks of major cardiovascular events (composite of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes) associated with different BP control goals.
RESULTS: A substantially lower proportion of hypertensive adults met BP goals of the SPRINT criteria compared with the 2014 recommendations (11.9% vs. 70.8%, respectively). Ten-year predicted cardiovascular risks were lowest in the intensive control group (below SPRINT BP goals), intermediate in the less-intensive group (above SPRINT goals but below 2014 recommendation goals), and highest in the uncontrolled group (above 2014 recommendations) (6.15%, 7.65%, and 9.39%, respectively; p < 0.001). After multivariable adjustment, the less-intensive and uncontrolled groups had a greater risk of major cardiovascular events (hazard ratios 1.17 and 1.62, respectively; p value for trend, <0.001) than the intensive group.
CONCLUSIONS: Substantially fewer hypertensive adults would meet SPRINT BP goals than would meet 2014 recommendation goals. Stricter BP control is associated with a decreased risk of major cardiovascular events.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blood pressure; cardiovascular events; hypertension

Mesh:

Substances:

Year:  2016        PMID: 27311520     DOI: 10.1016/j.jacc.2016.03.572

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

Review 1.  The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.

Authors:  Mark Houston
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01-10

Review 2.  Role of Coronary Calcium for Risk Stratification and Prognostication.

Authors:  Negin Nezarat; Michael Kim; Matthew Budoff
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

3.  Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation.

Authors:  Neal A Chatterjee; Claudia U Chae; Eunjung Kim; M Vinayaga Moorthy; David Conen; Roopinder K Sandhu; Nancy R Cook; I-Min Lee; Christine M Albert
Journal:  JACC Heart Fail       Date:  2017-06-14       Impact factor: 12.035

4.  Cardiovascular disease risk factor profile of male Gaelic Athletic Association sports referees.

Authors:  Catherine Noelle O'Riordan; Micheál Newell; Gerard Flaherty
Journal:  Ir J Med Sci       Date:  2018-03-27       Impact factor: 1.568

5.  Fixed and Low-Dose Combinations of Blood Pressure-Lowering Agents: For the Many or the Few?

Authors:  Massimo Leggio; Augusto Fusco; Claudia Loreti; Giorgio Limongelli; Maria Grazia Bendini; Andrea Mazza; Antonio Frizziero; Daniele Coraci; Luca Padua
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

Review 6.  Circadian Regulation of Blood Pressure: of Mice and Men.

Authors:  Megan K Rhoads; Vikhram Balagee; S Justin Thomas
Journal:  Curr Hypertens Rep       Date:  2020-05-21       Impact factor: 4.592

7.  Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban.

Authors:  Paulus Kirchhof; Sylvia Haas; Pierre Amarenco; Susanne Hess; Marc Lambelet; Martin van Eickels; Alexander G G Turpie; A John Camm
Journal:  J Am Heart Assoc       Date:  2020-02-21       Impact factor: 5.501

8.  Relation Between Blood Pressure and Clinical Outcome in Hypertensive Subjects With Previous Stroke.

Authors:  Chan Joo Lee; Jinseub Hwang; Jaewon Oh; Sang-Hak Lee; Seok-Min Kang; Hyeon Chang Kim; Sungha Park
Journal:  J Am Heart Assoc       Date:  2017-12-06       Impact factor: 5.501

9.  Value of electrocardiographic left ventricular hypertrophy as a predictor of poor blood pressure control: Evidence from the China stroke primary prevention trial.

Authors:  Zhenzhen Wang; Chunyan Zhang; Huihui Bao; Xiao Huang; Fangfang Fan; Yan Zhao; Juxiang Li; Jing Chen; Kui Hong; Ping Li; Yanqing Wu; Qinghua Wu; Binyan Wang; Xiping Xu; Yigang Li; Yong Huo; Xiaoshu Cheng
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.